High pre-treatment CD8 + T-cell density, high CD4 + T-cell density and low Myeloid-Derived Suppressor Cell density is associated with a higher likelihood of tumour regression and achieving a pCR [87, 91, 92]. The gene discussed is CD8A; the disease is neoplasm.